CHU de Québec-Université Laval Research Centre, Population Health and Optimal Health Practices Axis, Québec, QC, Canada.
Laval University, Faculty of Pharmacy, Québec, QC, Canada.
Can J Aging. 2023 Mar;42(1):126-134. doi: 10.1017/S0714980822000058. Epub 2022 May 10.
Reliable treatment burden measures are needed given the aging population and the associated increase in multimorbidity and polypharmacy. Treatment burden is defined as the effort to care for one's health and the resulting impact on one's daily life. This study aimed to translate the Multimorbidity Treatment Burden Questionnaire (MTBQ) for French-Canadians and assess its reliability and validity. The MTBQ was translated and tested with cognitive debriefing interviews, and the French version (MTBQ-F) was then administered 2 times among 105 participants. Reliability and validity were examined using the intra-class correlation coefficient (ICC), Cronbach's alpha, and Spearman's correlations. The median global MTBQ-F scores were 32.69 (interquartile range [IQR]: 21.15-48.08) and 30.77 (IQR: 21.15-46.15) for the first and second administrations, respectively. Test-retest (ICC: 0.73; 95% CI: 0.63-0.81) and internal consistency reliability (Cronbach's alpha: 0.80) were good. There was a moderate positive correlation between the MTBQ-F score and the number of self-reported conditions (rho: 0.28). This valid instrument could identify patients experiencing a high treatment burden and assess the impact of interventions among them.
鉴于人口老龄化以及随之而来的多种疾病和多种药物治疗的增加，需要可靠的治疗负担衡量标准。治疗负担被定义为照顾自己健康的努力以及对日常生活的影响。本研究旨在翻译法语版加拿大人群的多疾病治疗负担问卷（MTBQ），并评估其可靠性和有效性。使用认知访谈对 MTBQ 进行了翻译和测试，然后在 105 名参与者中进行了两次法语版 MTBQ（MTBQ-F）的测试。使用组内相关系数（ICC）、克朗巴赫 α 系数和斯皮尔曼相关性来评估可靠性和有效性。第一次和第二次 MTBQ-F 评分的中位数分别为 32.69（四分位距 [IQR]：21.15-48.08）和 30.77（IQR：21.15-46.15）。测试-重测（ICC：0.73；95%CI：0.63-0.81）和内部一致性可靠性（克朗巴赫 α：0.80）良好。MTBQ-F 评分与自我报告的疾病数量之间存在中度正相关（rho：0.28）。该有效工具可识别出治疗负担较重的患者，并评估干预措施对他们的影响。
